Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia

D. K. Kalwinsky, P. Roberson, G. Dahl, J. Harber, G. Rivera, W. P. Bowman, C. H. Pui, J. Ochs, M. Abromowitch, M. E. Costlow

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Improvements in therapy for childhood acute lymphoblastic leukemia (ALL) have led us to reevaluate the prognostic significance of lymphoblast characteristics at diagnosis. From application of univariate and multivariate statistical methods, we determined the relationship of five blast cell features to treatment outcome in 250 patients who were enrolled in two clinical trials at this center from May 1979 through April 1982. Karotype ploidy, lymphoblast morphology, and immunophenotype were each significantly related to prognosis as measured by time to failure, while periodic acid-Schiff reactivity and glucocorticoid receptor number lacked prognostic implication for this patient population. In addition, clinical features of initial WBC count, age, and race were also significant independent variables in predicting treatment response. By multivariate analysis, both ploidy and morphology contributed prognostic information to a clinical model based on WBC count, age, and race. If the model was adjusted for impact of ploidy, however, French-American-British morphology no longer contributed additional prognostic information. Our findings suggest that many traditional biological features used to estimate prognosis in ALL can be discarded in favor of clinical features (leukocyte count, age, and race) and cytogenetics (ploidy) for planning of future clinical trials.

Original languageEnglish (US)
Pages (from-to)477-484
Number of pages8
JournalJournal of Clinical Oncology
Volume3
Issue number4
DOIs
StatePublished - Jan 1 1985

Fingerprint

Ploidies
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Clinical Trials
Periodic Acid
Glucocorticoid Receptors
Leukocyte Count
Cytogenetics
Multivariate Analysis
Therapeutics
Population

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kalwinsky, D. K., Roberson, P., Dahl, G., Harber, J., Rivera, G., Bowman, W. P., ... Costlow, M. E. (1985). Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 3(4), 477-484. https://doi.org/10.1200/JCO.1985.3.4.477

Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia. / Kalwinsky, D. K.; Roberson, P.; Dahl, G.; Harber, J.; Rivera, G.; Bowman, W. P.; Pui, C. H.; Ochs, J.; Abromowitch, M.; Costlow, M. E.

In: Journal of Clinical Oncology, Vol. 3, No. 4, 01.01.1985, p. 477-484.

Research output: Contribution to journalArticle

Kalwinsky, DK, Roberson, P, Dahl, G, Harber, J, Rivera, G, Bowman, WP, Pui, CH, Ochs, J, Abromowitch, M & Costlow, ME 1985, 'Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia', Journal of Clinical Oncology, vol. 3, no. 4, pp. 477-484. https://doi.org/10.1200/JCO.1985.3.4.477
Kalwinsky, D. K. ; Roberson, P. ; Dahl, G. ; Harber, J. ; Rivera, G. ; Bowman, W. P. ; Pui, C. H. ; Ochs, J. ; Abromowitch, M. ; Costlow, M. E. / Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia. In: Journal of Clinical Oncology. 1985 ; Vol. 3, No. 4. pp. 477-484.
@article{9532fadc915a417097339d7b1fb951fa,
title = "Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia",
abstract = "Improvements in therapy for childhood acute lymphoblastic leukemia (ALL) have led us to reevaluate the prognostic significance of lymphoblast characteristics at diagnosis. From application of univariate and multivariate statistical methods, we determined the relationship of five blast cell features to treatment outcome in 250 patients who were enrolled in two clinical trials at this center from May 1979 through April 1982. Karotype ploidy, lymphoblast morphology, and immunophenotype were each significantly related to prognosis as measured by time to failure, while periodic acid-Schiff reactivity and glucocorticoid receptor number lacked prognostic implication for this patient population. In addition, clinical features of initial WBC count, age, and race were also significant independent variables in predicting treatment response. By multivariate analysis, both ploidy and morphology contributed prognostic information to a clinical model based on WBC count, age, and race. If the model was adjusted for impact of ploidy, however, French-American-British morphology no longer contributed additional prognostic information. Our findings suggest that many traditional biological features used to estimate prognosis in ALL can be discarded in favor of clinical features (leukocyte count, age, and race) and cytogenetics (ploidy) for planning of future clinical trials.",
author = "Kalwinsky, {D. K.} and P. Roberson and G. Dahl and J. Harber and G. Rivera and Bowman, {W. P.} and Pui, {C. H.} and J. Ochs and M. Abromowitch and Costlow, {M. E.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1200/JCO.1985.3.4.477",
language = "English (US)",
volume = "3",
pages = "477--484",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "4",

}

TY - JOUR

T1 - Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia

AU - Kalwinsky, D. K.

AU - Roberson, P.

AU - Dahl, G.

AU - Harber, J.

AU - Rivera, G.

AU - Bowman, W. P.

AU - Pui, C. H.

AU - Ochs, J.

AU - Abromowitch, M.

AU - Costlow, M. E.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Improvements in therapy for childhood acute lymphoblastic leukemia (ALL) have led us to reevaluate the prognostic significance of lymphoblast characteristics at diagnosis. From application of univariate and multivariate statistical methods, we determined the relationship of five blast cell features to treatment outcome in 250 patients who were enrolled in two clinical trials at this center from May 1979 through April 1982. Karotype ploidy, lymphoblast morphology, and immunophenotype were each significantly related to prognosis as measured by time to failure, while periodic acid-Schiff reactivity and glucocorticoid receptor number lacked prognostic implication for this patient population. In addition, clinical features of initial WBC count, age, and race were also significant independent variables in predicting treatment response. By multivariate analysis, both ploidy and morphology contributed prognostic information to a clinical model based on WBC count, age, and race. If the model was adjusted for impact of ploidy, however, French-American-British morphology no longer contributed additional prognostic information. Our findings suggest that many traditional biological features used to estimate prognosis in ALL can be discarded in favor of clinical features (leukocyte count, age, and race) and cytogenetics (ploidy) for planning of future clinical trials.

AB - Improvements in therapy for childhood acute lymphoblastic leukemia (ALL) have led us to reevaluate the prognostic significance of lymphoblast characteristics at diagnosis. From application of univariate and multivariate statistical methods, we determined the relationship of five blast cell features to treatment outcome in 250 patients who were enrolled in two clinical trials at this center from May 1979 through April 1982. Karotype ploidy, lymphoblast morphology, and immunophenotype were each significantly related to prognosis as measured by time to failure, while periodic acid-Schiff reactivity and glucocorticoid receptor number lacked prognostic implication for this patient population. In addition, clinical features of initial WBC count, age, and race were also significant independent variables in predicting treatment response. By multivariate analysis, both ploidy and morphology contributed prognostic information to a clinical model based on WBC count, age, and race. If the model was adjusted for impact of ploidy, however, French-American-British morphology no longer contributed additional prognostic information. Our findings suggest that many traditional biological features used to estimate prognosis in ALL can be discarded in favor of clinical features (leukocyte count, age, and race) and cytogenetics (ploidy) for planning of future clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0021986845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021986845&partnerID=8YFLogxK

U2 - 10.1200/JCO.1985.3.4.477

DO - 10.1200/JCO.1985.3.4.477

M3 - Article

C2 - 3872347

AN - SCOPUS:0021986845

VL - 3

SP - 477

EP - 484

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 4

ER -